Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: AbbVie Under Scrutiny: Divergent Opinions Surround Centre’s Updated UCPMP Code Compliance
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
First order under Centre’s updated UCPMP code, on Abbvie, sees divergent views
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Nation > AbbVie Under Scrutiny: Divergent Opinions Surround Centre’s Updated UCPMP Code Compliance
Nation

AbbVie Under Scrutiny: Divergent Opinions Surround Centre’s Updated UCPMP Code Compliance

Nation Desk By Nation Desk December 24, 2024 3 Min Read
Share
SHARE

The initial ruling under the revised Uniform Code for Pharmaceutical Marketing Practices (UCPMP 2024) has revealed a disagreement between the Department of Pharmaceuticals (DoP) and a pharmaceutical industry association regarding an alleged infringement by Abbvie Healthcare India Private Ltd.

The Apex Committee on Pharma Marketing Practices determined that Abbvie had violated the UCPMP by funding trips to Monaco and Paris for approximately 30 healthcare professionals (HCPs). The Committee reprimanded the multinational company for engaging in unethical marketing practices after reviewing an anonymous complaint and considering Abbvie’s response. The complaint alleged that Abbvie provided travel tickets and accommodations for lavish trips disguised as participation in conferences, specifically the Aesthetics & Anti-Aging Medicine World Congress 2024, held in February and March 2024. The involved doctors were associated with Abbvie’s products, Botox and Juvederm.

The complaint was referred to the ethics committee of the Organisation of Pharmaceutical Producers of India (OPPI), which primarily represents multinational pharmaceutical companies. While OPPI concluded that there were no irregularities in Abbvie’s sponsorship of the 30 HCPs, the findings from the DoP’s Special Audit Committee contradicted this assessment.

Furthermore, the Apex Committee requested the Central Board of Direct Taxes to review Abbvie’s and the 30 HCPs’ tax obligations under the Income Tax Act. It also urged the National Medical Commission to take appropriate actions against the HCPs based on the regulations set forth by the Indian Medical Council regarding professional conduct and ethics. The total expenditure for the HCPs amounted to INR 1,91,24,991 (one crore ninety-one lakh twenty-four thousand nine hundred ninety-one rupees).

OPPI stated that because the UCPMP 2014 did not specifically address interactions between the industry and HCPs in their professional roles, the Medical Council of India Code of 2002 would apply. This code permits doctors to engage with the pharmaceutical and allied healthcare industries in various capacities, including as consultants, researchers, or treating physicians.

The allegations surrounding the two conferences, according to OPPI, fell under the governance of UCPMP 2014 and not the newly enacted UCPMP 2024, which came into effect on March 12, 2024. However, the Order responded by asserting that both the 2014 and 2024 codes share a fundamental principle: they prohibit pharmaceutical companies from providing “Travel and Hospitality” benefits to any healthcare professionals.

Regarding Abbvie’s assertion of having legitimate service agreements with the HCPs, the Order stated, “There seems to be no justifiable reason for 30 healthcare professionals to travel to Monaco and Paris for this purpose, nor can any reasonable individual dismiss the conclusion that such preferential treatment toward HCPs serves to promote Abbvie’s products, irrespective of the agreements’ terms. This arrangement undermines the spirit of both UCPMP 2014 and UCPMP 2024 and compromises the public good that these codes aim to uphold.”

TAGGED:National NewsNews
Share This Article
Twitter Copy Link
Previous Article Of the 3 IPOs, Senores Pharma steals limelight with 93.4x bids Senores Pharma IPO shines with 93.4x bids in standout debut.
Next Article Tamil Nadu: MK Stalin urges EAM S Jaishankar to act swiftly: 17 Indian fishermen detained by Sri Lankan navy Stalin Calls on EAM Jaishankar for Swift Action as 17 Indian Fishermen Detained by Sri Lankan Navy
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

India raises diesel and aviation turbine fuel export duty

India Increases Export Duty on Diesel and Aviation Turbine Fuel to Boost Revenue

November 17, 2026
Photos: California residents gather to watch massive El Nino-fuelled waves

Massive El Niño Waves Draw California Residents to Coastal Viewing Spots

November 17, 2026
EU anti-dumping duties on Indian steel: JSW Steel, Tata Steel face 9.5% tariff

EU Imposes 9.5% Tariff on Indian Steel: Impact on JSW Steel and Tata Steel

November 16, 2026
Associated Alcohols enters Tequila segment, shares hit 52-week low as Q2 profits slide 43%

Associated Alcohols Ventures into Tequila Market, Shares Plummet to 52-Week Low Amid 43% Profit Drop

November 16, 2026
Stock Market Today Live, Nov 16: Sensex, Nifty pare early gains as investors assess sustainability of market rally

Market Update: Sensex and Nifty Trim Early Gains Amid Investor Concerns on Rally Longevity

November 16, 2026
Mahindra's electric three-wheeler arm eyes IPO in 18 months

Mahindra’s Electric Three-Wheeler Division Plans IPO Within 18 Months Amid Growing Demand

November 16, 2026

You Might Also Like

Gold dips to ₹80,580, silver drops ₹1,300
Economy

Precious Metals Experience Price Declines: Gold at ₹80,580 and Silver at ₹1,300 Decrease

2 Min Read
NSE/BSE, Top Gainers & Top Losers Today 15 September 2025: Bajaj Finance, Eternal, UltraTech Cement, Reliance, SBI
Economy

Top Gainers and Losers on NSE/BSE: Bajaj Finance, Reliance, SBI

2 Min Read
Rupee to encounter fresh strain as Fed's hawkish tilt compounds oil pain
Economy

Rupee Faces New Pressure as Fed’s Hawkish Stance Intensifies Oil Price Challenges

3 Min Read
Bullion Cues: Strong momentum  - The HinduBusinessLine
Economy

Bullion Market Surge: Unraveling Strong Trends Impacting Gold and Silver Prices Today

5 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?